BioStem Technologies, Inc. (BSEM)
NASDAQ: BSEM · Real-Time Price · USD
3.680
+0.335 (10.01%)
Aug 20, 2026, 4:00 PM EDT - Market closed
BioStem Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 34.59 | 47.48 | 69.66 | 16.69 | 6.88 | 4.34 | |
Revenue Growth | -49.13% | -31.84% | 317.48% | 142.69% | 58.38% | 1284.88% |
Cost of Revenue | 6.94 | 3.04 | 13.74 | 1.26 | 0.88 | 1.47 |
Gross Profit | 27.65 | 44.44 | 55.92 | 15.42 | 5.99 | 2.87 |
Selling, General & Admin | 44.34 | 37.82 | 22.67 | 21.91 | 10.21 | 4.07 |
Research & Development | 5.31 | 7.09 | 1.91 | 0.34 | 0.22 | 0.12 |
Operating Expenses | 50.98 | 45.13 | 24.79 | 22.48 | 10.67 | 4.47 |
Operating Income | -23.34 | -0.69 | 31.12 | -7.06 | -4.68 | -1.61 |
Interest Expense | - | - | -0.62 | -0.7 | -0.47 | -0.53 |
Interest & Investment Income | 0.41 | 0.41 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.11 | -0.11 | 0.03 | -0 | 0 | 0.03 |
EBT Excluding Unusual Items | -23.04 | -0.39 | 30.53 | -7.76 | -5.15 | -2.1 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.03 |
Legal Settlements | - | - | - | -0.72 | - | - |
Other Unusual Items | -0.6 | - | - | - | -2.08 | 0.66 |
Pretax Income | -23.64 | -0.39 | 30.53 | -8.48 | -7.23 | -1.41 |
Income Tax Expense | 4.65 | 6.19 | -0.5 | - | - | - |
Earnings From Continuing Operations | -28.29 | -6.58 | 31.03 | -8.48 | -7.23 | -1.41 |
Minority Interest in Earnings | - | - | - | - | 0.04 | -0.03 |
Net Income | -28.29 | -6.58 | 31.03 | -8.48 | -7.19 | -1.45 |
Net Income to Common | -28.29 | -6.58 | 31.03 | -8.48 | -7.19 | -1.45 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 17 | 17 | 16 | 14 | 11 | 12 |
Shares Outstanding (Diluted) | 17 | 17 | 22 | 14 | 11 | 12 |
Shares Change | -26.89% | -22.90% | 58.30% | 20.18% | -2.40% | 130.37% |
EPS (Basic) | -1.67 | -0.39 | 1.90 | -0.62 | -0.63 | -0.12 |
EPS (Diluted) | -1.67 | -0.39 | 1.43 | -0.62 | -0.63 | -0.12 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.83 | 6.59 | 24.04 | -3.6 | 0.06 | -0.15 |
Free Cash Flow Per Share | -0.52 | 0.39 | 1.11 | -0.26 | 0.01 | -0.01 |
Gross Margin | 79.94% | 93.59% | 80.27% | 92.44% | 87.17% | 66.03% |
Operating Margin | -67.47% | -1.45% | 44.68% | -42.30% | -68.09% | -36.99% |
Profit Margin | -81.80% | -13.86% | 44.55% | -50.84% | -104.62% | -33.30% |
Free Cash Flow Margin | -25.54% | 13.88% | 34.51% | -21.60% | 0.87% | -3.51% |
EBITDA | -22 | -0.47 | 31.34 | -6.83 | -4.46 | -1.32 |
EBITDA Margin | -63.61% | -0.99% | 44.99% | -40.93% | -64.86% | -30.45% |
D&A For EBITDA | 1.33 | 0.22 | 0.21 | 0.23 | 0.22 | 0.28 |
EBIT | -23.34 | -0.69 | 31.12 | -7.06 | -4.68 | -1.61 |
EBIT Margin | -67.47% | -1.45% | 44.68% | -42.30% | -68.09% | -36.99% |
Advertising Expenses | - | 1.35 | 0.49 | 0.2 | 0.09 | 0.07 |